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Abstract
The prevalence of atopic eczema has been found to have increased greatly in some parts of the world. Building on a
systematic review of global disease trends in asthma, our objective was to study trends in incidence and prevalence of
atopic eczema. Disease trends are important for health service planning and for generating hypotheses regarding the
aetiology of chronic disorders. We conducted a systematic search for high quality reports of cohort, repeated cross-sectional
and routine healthcare database-based studies in seven electronic databases. Studies were required to report on at least
two measures of the incidence and/or prevalence of atopic eczema between 1990 and 2010 and needed to use comparable
methods at all assessment points. We retrieved 2,464 citations, from which we included 69 reports. Assessing global trends
was complicated by the use of a range of outcome measures across studies and possible changes in diagnostic criteria over
time. Notwithstanding these difficulties, there was evidence suggesting that the prevalence of atopic eczema was
increasing in Africa, eastern Asia, western Europe and parts of northern Europe (i.e. the UK). No clear trends were identified
in other regions. There was inadequate study coverage worldwide, particularly for repeated measures of atopic eczema
incidence. Further epidemiological work is needed to investigate trends in what is now one of the most common long-term
disorders globally. A range of relevant measures of incidence and prevalence, careful use of definitions and description of
diagnostic criteria, improved study design, more comprehensive reporting and appropriate interpretation of these data are
all essential to ensure that this important field of epidemiological enquiry progresses in a scientifically robust manner.
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Introduction
Atopic eczema is a very common inflammatory skin disorder
[1]. Its prevalence appears to vary across the world as noted in key
international epidemiological studies [2–5]. Such variation has
been found in both children and adults and points to the likely
importance of environmental risk factors. In addition, atopic
eczema has been shown to cluster in families and there is growing
evidence that it is an herald condition in many people who go on
to develop allergic problems affecting other organ systems (e.g.
food allergy) [6,7]. Genetics are important in the aetiology of
atopic eczema: in particular, recent genetic epidemiological studies
found a strong association between filaggrin gene defects (present
in 1 in 10 Europeans and North Americans), and atopic eczema
[7]. Filaggrin plays a role in maintaining the epidermal skin barrier
function, whereby it helps to retain moisture in the skin and limits
penetration by allergens. These functions can be impaired in
filaggrin loss-of-function mutations, this resulting in dry, scaly skin,
which increases the risk of allergic sensitisation and disease [7–9].
Monitoring disease trends over time aids aetiological under-
standing and helps with the planning of health services nationally
and internationally. Building on our previous work on asthma, we
sought to describe international trends in the incidence and
prevalence of atopic eczema [10]. We aimed to draw preferentially
on high quality studies using appropriate study designs and, in
particular, studies using validated instruments [such as the
International Study of Asthma and Allergies in Childhood
(ISAAC) or the European Community Respiratory Health Survey
(ECRHS)] [11,12].
Methods
This review is reported using the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement as a
guide (see Appendix S1) [13]. The methods for this review were
specified in advance and documented in a study protocol.
Our full search strategy is given in Appendix S2. In short, we
searched seven electronic databases, namely Medline, CINAHL,
Embase, Global Health, Global Health Library, Google Scholar
and Web of Knowledge, from 1 January 1990 to 19 May 2010
(date of last search). We used both Medical Subject Headings
(MeSH) and free text terms of the following concepts: (atopic
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eczema OR atopic dermatitis) AND (cohort studies OR cross-
sectional studies OR ISAAC OR ECRHS) AND (incidence OR
prevalence OR trend). The searches were not limited by age, sex,
ethnicity or language. Furthermore, bibliographies of key reports
were scanned and a citation search was conducted for any
additional papers of interest. We only included full-text reports of
cohort studies, repeated cross-sectional surveys or analyses of
routine healthcare datasets, as we considered these appropriate
designs for the assessment of disease trends. Studies were required
to present at least two estimates of atopic eczema incidence and/or
prevalence within the period 1990 to 2010 and, at each assessment
time point, they needed to use a similar approach and instrument
(see Table 1). The screening of titles and abstracts and the
eligibility assessment of full-text reports was independently
performed by two reviewers. Disagreements were resolved by
discussion or by a third reviewer if agreement could not be
reached. Similarly, to establish the methodological quality of each
study, the internal and external validity was examined using the
Critical Appraisal Skills Programme (CASP) tool [14] and scored
as ‘good’, ‘moderate’ or ‘poor’. This methodological assessment
included for example an appraisal of whether validated instru-
ments were used [i.e. at least one of the ISAAC key questions (see
Table 2)]. Reviewers were not masked when assessing study
quality. Incidence and/or prevalence data as well as study and
participant characteristics were extracted onto a customised data
extraction sheet by one reviewer and thoroughly checked by the
second reviewer.
To compare disease trends, our primary outcome measure was
the lifetime prevalence of symptoms suggestive of atopic eczema or
the incidence of atopic eczema (see Table 3). We also collected
data on the secondary outcomes, such as the lifetime prevalence of
physician-diagnosed eczema or 12-month prevalence measures.
There was too much heterogeneity of populations studied and
methods employed to undertake meta-analysis.
Results
Our searches retrieved 2,464 titles from which we identified 70
papers that satisfied our inclusion criteria (see Figure 1). We
excluded one of these studies because the full-text paper was only
available in Korean [15] and we were unable to procure a
translation; there were therefore 69 papers in our final dataset.
Data from included studies judged to be of moderate or good
quality are summarised in Table 4 and explored descriptively by
region (see Tables 5, 6, 7, 8 and 9) [16]. Data from the primary
outcomes are additionally represented on a map (see Figure 2).
Data from studies judged to be at greater risk of bias are available
from the corresponding author [17–22]. Nearly all studies had
prevalence data, while incidence data were only reported in three
European studies [23–25]. Prevalence data are described using
lifetime prevalence of atopic eczema symptoms.
Africa
As presented in Table 4, we found four studies on atopic eczema
trends for Africa [26–29]. Incidence was not measured in any of
these studies. Prevalence was measured based on parental- or self-
report as assessed by ISAAC-based questions (see Table 5). Data
were mainly from 13–14 year old children and in these children
the general trend in Africa (Kenya, Morocco and South Africa) for
the prevalence of atopic eczema was increasing [25,27,28]
[26,27,29]. In these children, an approximate doubling of the
lifetime prevalence of atopic eczema symptoms was found for
Morocco [e.g. flexural rash in Marrakech, Morocco – from 9.9%
(1995) to 20.9% (2001–02)] [26], for South Africa [e.g. flexural
rash – from 10.2% (1995) to 16.5% (2002)] [29] and for Kenya
[e.g. itchy recurrent rash in flexural areas – from 11.4% (1995) to
19.8% (2001)] [27]. In Nigeria in children of this age group, the
lifetime prevalence of itchy rash decreased from a high baseline
prevalence [from 26.1% (1995) to 18.0% (2001–02)] [28].
Prevalence estimates in 2001–02 were, however, comparable for
all countries. An approximate doubling was also seen in the
lifetime prevalence of physician-diagnosed atopic eczema in 13–14
year olds in South Africa and Kenya [27,29]. In contrast, the
prevalence of physician-diagnosed atopic eczema in Nigeria
considerably decreased over a 5-year period from 1995 to 2001
in 6–7 year olds [from 9.4% to 6.8%] and in 13–14 year olds
[from 38.4% to 19.4%] [28]. The baseline estimate for 13–14 year
Table 1. Inclusion criteria.
1. Epidemiological design (e.g. cohort, repeated cross-sectional or routine health care)
2. Estimates of eczema incidence and or prevalence at least twice within the period 1990–2010
3. Use of a comparable approach and instrument to measure eczema at each time point.
doi:10.1371/journal.pone.0039803.t001
Table 2. Key question for atopic eczema from the ISAAC questionnaire.
Have you ever had an itchy rash which was coming and going for at least six months?
Have you had this itchy rash at any time in the last 12 months?
Has this itchy rash at any time affected any of the following places: the folds of the elbows, behind the knees, in front of the ankles, under the buttocks, or around the
neck, ears or eyes?
At what age did this itchy rash first occur; under 2 years, age 2-4 years or age 5 or more?
Has this rash cleared completely at any time during the last 12 months?
In the last 12 months, how often, on average, have you been kept awake at night by this itchy rash; never in the last 12 months, less than one night per week or one or
more nights per week?
Have you ever had eczema?
doi:10.1371/journal.pone.0039803.t002
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olds was again extremely high. In other African countries, single
estimates of atopic eczema prevalence may have been reported,
but we were unable to locate any serial data on trends.
Asia
For Asia, we summarised 20 papers representing 61 measures of
trends in Table 4. The majority of data came from eastern Asia
[30–39], whereas south-eastern Asia [40–43] and western Asia
[44–49] were represented to a lesser extent. For other regions in
Asia, we found no relevant data. Here too no study assessed trends
in incidence; rather, each study measured prevalence as based on
parental- or self-report by questionnaires (see Tables 6). Trends
were found for different age groups in 12 different countries and
showed no overall pattern.
In eastern Asia, the general trend for atopic eczema prevalence
was mainly increasing across different age groups. Lee et al. (2007)
reported an increase in the sex- and age-standardised lifetime
prevalence of ISAAC-based parental-report of atopic eczema
symptoms in Taiwan among 12–15 year olds [from 2.4% (1995–
96) to 4.0% (2001)] [32]. The lifetime prevalence of atopic eczema
symptoms also increased in Korea in the same age group [from
7.2% (1995) to 9.3% (2000)] [36], in China (Guangzhou city) in a
similar age group 13–14 [from 1.7% (1994–95) to 3.0% (2001)] [37]
and in Japan in a wider-ranged age group 7–15 [from 10.1% (1996)
to 13.6% (2006)] [39]. Moreover, baseline prevalences were low,
but considerably higher in Korea and Japan, compared to Taiwan
and China. In a slightly younger age group 6–12 in Korea, atopic
eczema symptoms showed a modest increase from a substantially
higher baseline prevalence [from 15.3% (1995) to 17.0% (2000)]
[36]. In the youngest children aged 6–7, the prevalence of atopic
eczema symptoms was stable in Hong Kong [e.g. chronic rash –
from 5.7% (1995) to 5.4% (2001)] [31], whilst a modest increase was
seen in a later study in Taiwan in a similar age group 6–8 [e.g.
chronic rash - from 5.8% (2002) to 7.7% (2007)] [34]. Trends in the
lifetime prevalence of physician-diagnosed atopic eczema followed
nearly the same pattern as the lifetime prevalence of atopic eczema
symptoms; trends were increasing in most countries among different
age groups with only few exceptions.
In south-eastern Asia, the prevalence of different atopic eczema
symptoms showed mixed trends. For chronic rash, the lifetime
prevalence was stable in 6–7 year olds in Singapore [10.5% (1994)
and 12.5% (2001)] [42] and in north-eastern Thailand [18.0%
Table 3. Primary and secondary outcomes measures.
Primary outcomes Lifetime prevalence of atopic eczema symptoms
Incidence of atopic eczema
Secondary outcomes Lifetime prevalence of physician diagnosis of atopic eczema
12-month prevalence of atopic eczema symptoms
12-month prevalence of physician diagnosis of atopic eczema
doi:10.1371/journal.pone.0039803.t003
Figure 1. PRISMA flow diagram.
doi:10.1371/journal.pone.0039803.g001
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(1998–99) and 17.2% (2003)] [41]. Moreover, this prevalence also
remained stable in older children (aged 12–15) in Singapore and,
even though the baseline prevalence was appreciably lower, in 13–
14 year olds in north-eastern Thailand. For chronic rash with a
typical distribution, however, the lifetime prevalence was increas-
ing in Singapore in children of both age groups [e.g. in 6–7 year
olds – from 6.1% (1994) to 9.8% (2001)] [43]. In Malaysia and two
specific geographical areas in Thailand (Chiang Mai and Bangkok)
only data regarding the 12-month prevalence of atopic eczema
symptoms were available [40,41]. In Malaysia and Chiang Mai,
the 12-month prevalence of atopic eczema symptoms increased in
6–7 year olds, but was stable in 13–14 year olds, whereas the
opposite was seen in Bangkok.
In western Asia, data were found for Georgia, Kuwait, Turkey
and Israel [44–49]. In Georgia, the lifetime prevalence of atopic
eczema symptoms was found to be decreasing in two different
geographical areas among 6–7 year olds: in Tbilisi [from 4.5%
(1996) to 3.4% (2003)] and in Kutaisi [from 5.2% (1996) to 2.4%
(2003)] [44]. This trend was additionally apparent in the lifetime
prevalence of physician-diagnosed atopic eczema in these children.
There was also a decrease in the prevalence of atopic eczema
symptoms in 13–14 year old children from Kuwait [from 17.5%
(1995–96) to 10.6% (2001–02)], but the baseline prevalence was
much higher [48]. In Israel, the lifetime prevalence of itchy rash in
a distribution suggestive of atopic eczema was found to be
increasing [from 5.9% (1997) to 8.7% (2003)] [49]. In Turkey, two
measures of the prevalence of physician-diagnosed atopic eczema
were reported. The lifetime prevalence was stable in 6–13 year old
children [6.1% (1992) and 6.5% (2007)] [47], whilst the 12-month
prevalence was reported to have decreased over a 15-year period
in 7–12 year old children [from 4.0% (1992) to 1.2% (2007)] [46].
The Americas
We found no studies on atopic eczema trends for North
America, one study for Central America [50] and four studies for
South America [51–54] (see Table 4). No studies reported an
incidence trend. The study from Central America, which was
conducted in Mexico in 6–8 and 11–14 year old children (see
Table 7) [50]. This study showed a sharply decreasing lifetime
(and 12-month) prevalence of itchy rash in both age groups [e.g. in
6–8 year olds – from 15.0% (1995) to 7.3% (2002)] and,
conversely, a from low baseline increasing lifetime prevalence of
physician-diagnosed atopic eczema in both age groups [e.g. in 6–8
year olds – from 3.9% (1995) to 6.1% (2002)].
All four studies from South America were from Brazil and each
study included only trends in prevalence as based on parental- or
self-report by questionnaires (see Table 7) [51–54]. Two studies
measured the lifetime prevalence of atopic eczema symptoms and
showed a stable trend among 6–7 and 13–14 year olds [e.g. itchy
rash in Sa˜o Paulo in 6–7 year olds - 13.6% (1996) and 15.0%
(1999)] [51,52]. In another study, the 12-month prevalence of
itchy rash remained stable in children aged 13–14 years old [6.3%
(1995) and 6.0% (2001)] [53], whereas in the last study both the
lifetime prevalence of physician-diagnosed atopic eczema and the
12-month prevalence of atopic eczema symptoms were decreasing
in 13–14 year olds across five centres [e.g. physician-diagnosed
atopic eczema - from 5.3% (1994–95) to 4.5% (2001–03)] [54].
Europe
The largest set of reports (n = 31) on atopic eczema trends is for
Europe. The majority of all trends were increasing, although
decreasing and stable trends were found in some areas (see
Table 4).
Incidence. Three studies reported on incidence trends in
atopic eczema in Europe [23–25]. In Denmark, the adjusted
cumulative incidence of the UK Working Party-based parental-
report of physician-diagnosed atopic eczema in 7 year olds was
18.9% in 1993 and 19.6% in 1998 (see Table 8). Compared to the
survey of 1993 the sample size was over nine times larger in the
survey of 1998 [23]. Further, the cumulative incidence of parental-
Table 4. Summary of trends in different atopic eczema outcomes between 1990 and 2010 by region*.
Region Papers Trends Incidence Lifetime prevalence 12-month prevalence
(n) (n) symptoms diagnosis symptoms diagnosis
q « Q q « Q q « Q q « Q q « Q
Africa 4 20 0 0 0 9 0 1 2 0 2 4 1 1 0 0 0
Asia 20 61
eastern 10 27 0 0 0 7 2 0 7 1 1 7 1 0 0 0 1
south-eastern 4 20 0 0 0 2 4 0 1 3 0 4 6 0 0 0 0
western 6 14 0 0 0 1 0 3 0 3 2 0 2 2 0 0 1
Americas 5 21
North 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Central 1 6 0 0 0 0 0 2 2 0 0 0 0 2 0 0 0
South 4 15 0 0 0 0 5 0 0 1 3 0 5 1 0 0 0
Europe 31 101
western 10 42 1 1 0 4 2 0 12 5 0 4 9 0 0 0 4
southern 4 15 0 0 0 1 1 0 4 1 0 5 1 0 2 0 0
northern 15 41 1 1 0 9 1 1 15 1 0 8 2 1 0 1 0
eastern 2 3 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0
Oceania 3 4 0 0 0 1 0 0 1 1 0 1 0 0 0 0 0
*Based on UN classification [16].
doi:10.1371/journal.pone.0039803.t004
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report of history of physician-diagnosed atopic eczema in 5–6 year
olds was stable in West Germany [12.5% (1991) and 12.8%
(1997)], whilst it increased sharply in East Germany [from 9.6%
(1991) to 23.4% (1997)] [24]. Finally, the age- and sex-
standardised incidence of physicians’ recorded atopic eczema
diagnosis as based on secondary analysis of QRESEARCH, a
large primary care dataset (n = 333,294) in England, increased
from 9.6% (2001) to 13.6% (2005) per 1000 patient-years [25].
Prevalence. Prevalence data on trends in atopic eczema for
western Europe are shown in Table 9 [24,55–63]. Parental- and
self-report of atopic eczema symptoms were reported in five
countries [55,56,59,60,62,63]. The lifetime prevalence of atopic
eczema symptoms increased in 5–7 year old children in
Switzerland [from 11.7% (1992) to 17.4% (2001)] [56] and in
slightly older children (aged 6–9) in Austria, but from a lower
baseline [from 9.2% (1995–97) to 11.0% (2001–03)] [63]. This
lifetime prevalence of atopic eczema symptoms also increased in
Belgium, both in boys and girls aged 6–7 [e.g. in boys - from
12.9% (1995–96) to 18.4% (2002)], whilst in 13–14 year old boys
and girls it remained stable [e.g. in boys 215.7% (1995–96) and
13.3% (2002)] [62]. We found no data on the lifetime prevalence
of atopic eczema symptoms for Germany and France. In France,
the lifetime prevalence of physician-diagnosed atopic eczema
increased in 13–14 year olds [from 25.8% (1995) to 30.4% (2002)]
[55]. In Germany (Mu¨nster), this prevalence also increased in 13–
14 year olds [e.g. in boys - from 8.2% (1994–95) to 10.9% (1999–
2000)], whilst it showed a stable trend in 6–7 year olds [e.g. in boys
214.3% (1994–95) and 13.6% (1999–2000)] [60].
In southern Europe, the lifetime prevalence of atopic eczema
symptoms remained stable in the Maltese Islands in 5–8 year olds
[7.0% (1994–95) and 6.7% (2001–02)] [64] and increased in
Greece in older children (aged 8–10) [from 4.5% (1991) to 9.5%
(2003)] [65]. Here, the trend was measured over a longer time
period and started at a lower baseline level. In Italy and Portugal,
no lifetime prevalence trends for atopic eczema symptoms were
reported. The lifetime prevalence of physician-diagnosed atopic
eczema showed an increasing trend in 6–7 year olds in Italy [from
14.3% (1994–95) to 17.0% (2002)] [66] and in the same age group
in Portugal [from 18.6% (1993–94) to 21.0% (2002)] [67].
Compared to Italy and Portugal, the increase of physician-
diagnosed atopic eczema in the Maltese Islands in a similar age
group of 5–8 year olds was considerably larger and more than
doubled over a 7-year period, as it originated from a low baseline
[from 4.4% (1994–95) to 11.2% (2001–02)] [64].
For northern Europe, 15 papers reported on trends in atopic
eczema [23,25,68–80]. The prevalence of rash and rash with a
typical distribution was overall increasing in boys and girls and in
6–7 and 13–14 year olds in the UK [e.g. in 6–7 year old boys –
from 17.8% (1995–96) to 21.0% (2001–02)], although not all
trends reached significance [80]. Several other studies, which
measured the lifetime prevalence of physician-diagnosed atopic
eczema [68,71,75–77] or the lifetime prevalence of physicians’
recorded atopic eczema diagnosis [25,73] in the UK, also showed
increasing trends confirming patterns of atopic eczema prevalence
in the UK in children and across all age-groups over time. An
increasing trend for atopic eczema symptoms was also found in
Estonia in 6–7 year olds [from 16.9% (1993–94) to 22.0% (2001–
02)] [69]. However, in Sweden in slightly older children (aged 7–
8), the lifetime prevalence of atopic eczema symptoms was
decreasing [from 29.3% (1996) to 26.5% (2006)] [78]. Despite
this decrease, prevalence estimates remained higher as compared
to Estonia. There was no data on the lifetime prevalence of atopic
eczema symptoms available in Lithuania and Norway. In
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atopic eczema was increasing from an extremely low baseline
[from 1.4% (1994–95) to 3.5% (2002–03)] [72]. In Norway, this
prevalence was stable in 9–11 year olds [21.1% (1995) and 20.8%
(2000)] [79].
Two studies yielded relevant data in relation to eastern Europe.
In Poland, the lifetime prevalence of parental-reported physician-
diagnosed atopic eczema increase over a decade in children aged
7–10 [from 2.3% (1993) to 8.1% (2002)] [81]. Later, this same
prevalence, measured with a different questionnaire in both 7–9
and 7–14 year olds, remained stable in Hungary over a relatively
short time period [e.g. for 7–9 year olds –15.1% (2002) and 17.1%
(2005)] [82]. In Europe, there were many other countries with
single measurements of any atopic eczema outcome, but serial
data were not yet available.
Oceania
For Oceania, we found three papers from Australia with
prevalence data on atopic eczema trends (see Table 4) [83–85]. As
shown in Table 10, the lifetime prevalence of atopic eczema
symptoms was measured in Melbourne in 6–7 year olds, where it
markedly increased from 22.6% in 1993 to 32.3% in 2002 [84].
Two other studies measured trends in lifetime prevalence of atopic
eczema diagnosis. In one study this was increasing in 4–6 year
olds, even though the baseline prevalence was high [from 31.0%
(2000) to 37.0% (2005)] [83] and in another study, using a non-
validated questionnaire, it was stable in 8–11 year olds [85].
Discussion
The considerable body of international literature identified by
this systematic review was heterogeneous in many respects
rendering it difficult to directly compare different regions. That
said, there was no obvious consistent overall global trend in the
incidence or prevalence of atopic eczema symptoms and diagnosis.
Nevertheless, in Africa and eastern Asia there was an increasing
trend for both the lifetime prevalence of parental- and self-
reported atopic eczema symptoms and physician-diagnosed atopic
eczema. In western Europe and parts of northern Europe (i.e. the
UK), these trends were also mainly increasing. There were
extremely diverse trends among different age groups and countries
in south-eastern Asia, western Asia and southern Europe. In
addition, data for the Americas, eastern Europe and Oceania were
limited. The heterogeneous findings in some regions and the
limited data available for other regions have precluded conclusions
regarding a global atopic eczema trend and atopic eczema trends
in major parts of the world.
We found that many outcome measures are used across studies
to determine changes in atopic eczema prevalence. Although we
found that trends of all outcomes generally pointed in the same
direction, we considered the lifetime prevalence of parental- or
self-report of atopic eczema symptoms the optimal outcome for the
purpose of comparing disease trends between regions within our
highly heterogeneous dataset. As atopic eczema occurs in episodes
and may be season-related it is particularly difficult to compare
studies measuring current or 12-month symptomatology or if
patient- and/or study- characteristics, such as age group, do not
match. Furthermore, there are marked differences per region in
current medical practice, including prevention strategies, national
guidelines and physician’s awareness of the problem, that make
prevalence estimates and trends of physician-diagnosed atopic
eczema difficult to compare across the globe. Even though the
diagnostic process of a physician is overall likely to be standard-
ised, there is no objective gold standard. This is highlighted in the
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different terms to describe atopic eczema [86]. In addition, not
every language has disease labels, nor are they understood in the
same way. This means that a diagnostic label may be influenced
by region-specific guidelines for the diagnosis of atopic eczema and
this may therefore render it difficult to compare estimates of
physician-diagnosed atopic eczema prevalence between regions.
We thus judged that the lifetime prevalence of atopic eczema
symptoms was most likely to prove useful in relation to yielding
comparative data on trends in atopic eczema.
Strengths and limitations. To our knowledge, no system-
atic review on international disease trends in the incidence and
prevalence of atopic eczema has been published. We searched a
large amount of potential relevant literature using seven electronic
databases and included 69 papers which reported on trends in
atopic eczema. These should represent a good coverage of
published literature. Furthermore, we searched systematically,
according to a protocol and used stipulated inclusion criteria. To
ensure that included studies are above a specific quality threshold,
the studies were independently quality-filtered by two reviewers.
Where a consensus could not be obtained a third reviewer
provided arbitration guidance. In contrast with earlier work into
this field, we included all reports on atopic eczema trends, whereas
previously papers have limited themselves to single estimates of
atopic eczema [4,5], or to original data from the ISAAC study
[2,87].
There are gaps in the literature. We could include particularly
few reports from the Americas, eastern Europe and Oceania. In
general, studies are available on the prevalence of atopic eczema in
these regions. However, information from these studies will not be
relevant until they are repeated over time. This perhaps somewhat
surprising gap for North America is likely to be, at least in part,
due to the fact that the ISAAC programme had difficulty
identifying a regional coordinator for this region [88]. We were
unable to obtain the full-text translation of one Korean paper.
Nevertheless, we are reasonably confident that this report or any
other additional reports would be unlikely to undermine our
overall findings – that there is no clear trend in the worldwide
incidence and prevalence of atopic eczema. For nearly all regions
information on atopic eczema is questionnaire-based. Question-
naires are non-specific and the measured symptoms suggestive of
atopic eczema may overlap with symptoms of other conditions,
such as contact dermatitis. The ISAAC questionnaire stipulates
the typical distribution and the onset of the itchy rash (see Table 2),
which helps to enhance its specificity. At the population level and
particularly for the purpose of between-population comparison,
ISAAC questions are therefore likely to provide adequate
symptom-derived prevalence estimates [89]. That said there is
inevitably some loss of ability to differentiate between atopic
eczema and other differential diagnoses such as allergic contact
dermatitis. This problem may have been more pronounced had
we also identified studies using the ECRHS; in the event however,
no such relevant studies were found to be eligible.
Future work. Further research in this area should firstly
address methodological issues to help inform the optimum design,
execution and reporting of future epidemiological studies of trends
in atopic eczema. In our dataset various outcome measures were
reported and various assessment tools were used, data were
analysed differently across studies and results were reported in
Figure 2. World map of the incidence and lifetime prevalence of atopic eczema symptoms (1990–2010). Overview of absolute changes
in the incidence of atopic eczema and lifetime prevalence of atopic eczema symptoms between 1990 and 2010.
doi:10.1371/journal.pone.0039803.g002
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different formats (e.g. with and without confidence intervals (CI)),
age groups did not match and studies were inconsistently stratified
for sex. All of these factors enhance the incomparability of studies.
In view of the above, we suggest full and elaborate reporting of the
results (including CI) of all of the outcomes obtained. We
recommend that the above gaps be addressed using the complete
ISAAC tool (and, where possible, also include detailed clinical
assessment to allow atopic eczema to be differentiated from
allergic contact dermatitis) and be reported according to a
standardised format, so that comparisons to other reports on
trends are possible. However, even if studies are comparable the
prevalence of atopic eczema may still be difficult to compare
across countries, without a universal definition. Thus, we need a
range of relevant measures of incidence and prevalence as well as a
careful description of the diagnostic criteria used together with
appropriate interpretation of these data in order to ensure that this
important field of epidemiological enquiry progresses in a
scientifically robust manner.
Interpretation. Although there is no consistent overall global
trend in atopic eczema incidence and prevalence, there are some
specific trends which are worth remarking upon further, as they
may be of interest for research into the aetiology of atopic eczema.
Firstly, there was a stable incidence of atopic eczema in 5–6 year
olds in West Germany [12.5% (1991) and 12.8% (1997)] and a
sharply increasing incidence in East Germany [from 9.6% (1991)
to 23.4% (1997)] [24]. This coincides with the adoption of a
‘‘Western’’ lifestyle in East Germany as a result of political change.
A consequence of changed lifestyle and increased socio-economic
wealth may be an increased frequency of bathing and a greater
availability of soaps and bubble baths, which may remove the
skin’s natural barrier oils and make atopic eczema more prevalent
[90]. This is a biologically credible mechanism to explain an
increase in incidence – in particular of mild disease. Nevertheless,
Schafer et al. (2000) found that, after adjustment for potential
confounders, including socio-economic status, the difference in
incidence between East and West Germany remained [24]. Other
factors, such as nutritional factors, allergens and irritants or
infections may therefore be important in the aetiology of atopic
eczema. Political changes resulting in, for example, improved
access to physicians in East Germany after reunification or due to
changes in disease labelling could also have impacted on measures
of the incidence of atopic eczema, as has been noted in relation to
asthma diagnosis and prescribing [91]. If this were the case, this
would reflect an increase in reporting behaviour rather than any
true change in the epidemiology of eczema.
Other trends of interest regarding aetiological hypotheses
include diverging trends between neighbouring regions. For
example, there are marked increases in lifetime prevalence of
atopic eczema symptoms in most countries in Africa [e.g. in South
Africa – from 15.5% (1995) to 26.2% (2002)] [29], whereas there is
a large decrease in Nigeria [from 26.1% (1995) to 18.0% (2001–
02)] [27]. This anomalous decrease is most likely a consequence of
the extremely high baseline prevalence, as prevalence estimates in
2001–02 are largely comparable for all African countries. Rather
than a true prevalence, this high baseline estimate may be a
reflection of the presence of another skin condition, such as
another rash, perhaps caused by parasites, which are common in
these regions. In addition, in our dataset there were also marked
baseline differences between neighbouring countries. This is
indicated by the low baseline prevalence of atopic eczema
symptoms in 12–15 year olds in Taiwan [2.4% (1995–96)] [32]
and the much higher baseline prevalence in Korea [7.2% (1995)]
[36]. In these countries too, cultural, social and diagnostic
differences may potentially explain this pattern. In contrast, large
changes in prevalence estimates within one country in a short
space of time are of interest as such changes are likely to represent
a true change. For example the doubling in lifetime prevalence of
both atopic eczema diagnosis [from 13.9% (1995–96) to 27.2%
(2001–02)] and atopic eczema symptoms [from 8.8% (1995–96) to
19.6% (2001–02)] in boys aged 13–14 in England [80] is likely to
represent a true change and we must consider environmental
explanations for this.
In conclusion, we have found no overall trend for the incidence
or prevalence of atopic eczema worldwide. However, in Africa,
eastern Asia, western Europe and parts of northern Europe (i.e.
the UK) trends in atopic eczema prevalence were mainly
increasing. There are gaps in the literature, particularly in the
Americas and Oceania and for measures of atopic eczema
incidence. Future research should investigate trends in what is
now one of the most prevalent disorders in Europe and other
regions in a scientifically robust manner. In order to do so, the
careful use of key definitions, improved study design and more
comprehensive reporting are essential.
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